175 results on '"Kitko, Carrie L."'
Search Results
2. Comparison of treatment response measures in cutaneous sclerosis after allogeneic hematopoietic cell transplantation
3. Novel MAGIC composite scores using both clinical symptoms and biomarkers best predict treatment outcomes of acute GVHD
4. The MAGIC algorithm probability predicts treatment response and long-term outcomes to second-line therapy for acute GVHD
5. Amphiregulin, ST2, and REG3α biomarker risk algorithms as predictors of nonrelapse mortality in patients with acute GVHD
6. Immunophenotypic predictors of influenza vaccine immunogenicity in pediatric hematopoietic cell transplant recipients
7. Flares of acute graft-versus-host disease: a Mount Sinai Acute GVHD International Consortium analysis
8. A Day 14 Endpoint for Acute GVHD Clinical Trials
9. Phase 2 study of natalizumab plus standard corticosteroid treatment for high-risk acute graft-versus-host disease
10. Incidence, clinical presentation, risk factors, outcomes, and biomarkers in de novo late acute GVHD
11. A diagnostic classifier for pediatric chronic graft-versus-host disease: results of the ABLE/PBMTC 1202 study
12. Effective treatment of low-risk acute GVHD with itacitinib monotherapy
13. Differences in Acute Graft-Versus-Host Disease (GVHD) Severity and Its Outcomes Between Black and White Patients
14. KIR-favorable TCR-αβ/CD19-depleted haploidentical HCT in children with ALL/AML/MDS: primary analysis of the PTCTC ONC1401 trial
15. SARS-CoV-2 vaccine safety and immunogenicity in patients with hematologic malignancies, transplantation, and cellular therapies
16. Characteristics of Graft-Versus-Host Disease (GvHD) After Post-Transplantation Cyclophosphamide Versus Conventional GvHD Prophylaxis
17. Assessment of systemic and gastrointestinal tissue damage biomarkers for GVHD risk stratification
18. Metabolomic identification of α-ketoglutaric acid elevation in pediatric chronic graft-versus-host disease
19. Chronic Graft-versus-Host Disease, Nonrelapse Mortality, and Disease Relapse in Older versus Younger Adults Undergoing Matched Allogeneic Peripheral Blood Hematopoietic Cell Transplantation: A Center for International Blood and Marrow Transplant Research Analysis
20. A Validated Risk Stratification That Incorporates MAGIC Biomarkers Predicts Long-Term Outcomes in Pediatric Patients with Acute GVHD
21. Flares of Acute Graft-Versus-Host Disease (GVHD): A Mount Sinai Acute GVHD International Consortium (MAGIC) Analysis
22. Safety and Efficacy of Axatilimab in Patients with Chronic Graft-Versus-Host Disease (AGAVE-201)
23. Ibrutinib for Therapy of Steroid-Refractory Chronic Graft Vs. Host Disease: A Multicenter Real-World Analysis
24. The Mount Sinai Acute Gvhd International Consortium (MAGIC) Model: An Integrated Clinical and Biomarker Grading System for Acute Graft-Versus-Host Disease (GVHD)
25. Assessing Treatment Response in Cutaneous Sclerosis after Allogeneic Hematopoietic Cell Transplantation: A Chronic Gvhd Consortium Study
26. Graft Vs Host Disease (GVHD) in Pediatric Hematopoietic Stem Cell Transplant (HCT) Recipients and Impact on Overall Survival: A CIBMTR Analysis
27. The MAGIC Algorithm Probability Predicts Treatment Response and Long-Term Outcomes to Second-Line Therapy for Acute Gvhd
28. Effect of Autograft CD34+ Dose on Outcome in Pediatric Patients Undergoing Autologous Hematopoietic Stem Cell Transplant for Central Nervous System Tumors
29. A comprehensive assessment of the prolonged febrile neutropenia evaluation in pediatric oncology patients
30. The utility of biomarkers in acute GVHD prognostication
31. Children's Oncology Group's 2023 blueprint for research: Cellular therapy and stem cell transplantation
32. Pilot Study of Donor-Engrafted Clonal Hematopoiesis Evolution and Clinical Outcomes in Allogeneic Hematopoietic Cell Transplantation Recipients Using a National Registry
33. Immunophenotypic predictors of influenza vaccine immunogenicity in pediatric hematopoietic cell transplant recipients
34. A comprehensive assessment of the prolonged febrile neutropenia evaluation in pediatric oncology patients.
35. The Durability of Antibody Responses of Two Doses of High-Dose Relative to Two Doses of Standard-Dose Inactivated Influenza Vaccine in Pediatric Hematopoietic Cell Transplant Recipients: A Multi-Center Randomized Controlled Trial.
36. Evaluation of Elafin as a Prognostic Biomarker in Acute Graft-versus-Host Disease
37. Patient-reported treatment response in chronic graft-versus-host disease
38. Incidence of bacterial blood stream infections in patients with acute GVHD
39. Applying a risk prediction model for bloodstream infection in a febrile, nonseverely neutropenic cohort of pediatric stem cell transplant patients
40. CAR-T Prescriber Preferences in Adolescents and Young Adults with B-ALL
41. Leveraging the Pediatric Health Information System Database to Characterize Hospital Readmissions Following Pediatric Allogeneic Stem Cell Transplantation
42. De Novo Late Acute Gvhd: Incidence, Outcomes, and Impact of Biomarkers Compared to Classic Acute Gvhd
43. ABO Incompatibility Did Not Impact Outcomes after Haploidentical Bone Marrow Transplantation with Posttransplant Cyclophosphamide for Patients with Sickle Cell Disease: Single Center Experience
44. The Combination of Rituximab, Plasmapheresis, Intravenous Immunoglobulins and Pre-Transplant Immunosuppression Is an Effective Desensitization Strategy for Patients with Sickle Cell Disease and High Donor Specific Anti-Human Leukocyte Antigen Titer Undergoing Haploidentical Bone Marrow Transplant
45. Influenza Vaccine in Pediatric Recipients of Hematopoietic-Cell Transplants
46. Axatilimab for Chronic Graft-Versus-Host Disease After Failure of at Least Two Prior Systemic Therapies: Results of a Phase I/II Study
47. Three-year results from phase 1 of ZUMA-4: KTE-X19 in pediatric relapsed/refractory acute lymphoblastic leukemia
48. A diagnostic classifier for pediatric chronic graft-versus-host disease: results of the ABLE / PBMTC 1202 study
49. Axatilimab for Chronic Graft-Versus-Host Disease After Failure of at Least Two Prior Systemic Therapies: Results of a Phase I/II Study.
50. A Prospective, Multicenter Study of Closed-System Extracorporeal Photopheresis for Children with Steroid-Refractory Acute Graft-versus-Host Disease
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.